STAT Plus: Most innovative cancer drugs take too long to reach patients in the U.K.
DANIEL LEAL-OLIVAS/AFP/GETTY IMAGES
The analysis found that one key problem is drug makers generated an insufficient number of new treatments for cancers with the highest unmet medical need.


No hay comentarios:
Publicar un comentario